239 related articles for article (PubMed ID: 16960471)
1. Levetiracetam in tardive dyskinesia.
Meco G; Fabrizio E; Epifanio A; Morgante F; Valente M; Vanacore N; Di Rosa AE; Morgante L
Clin Neuropharmacol; 2006; 29(5):265-8. PubMed ID: 16960471
[TBL] [Abstract][Full Text] [Related]
2. Treatment of tardive dyskinesia with levetiracetam in a transplant patient.
Zivković SA; Costa G; Bond G; Abu-Elmagd KM
Acta Neurol Scand; 2008 May; 117(5):351-3. PubMed ID: 17995990
[TBL] [Abstract][Full Text] [Related]
3. Treatment of neuroleptic-induced tardive dyskinesia with levetiracetam: a case series.
Bona JR
J Clin Psychopharmacol; 2006 Apr; 26(2):215-6. PubMed ID: 16633158
[No Abstract] [Full Text] [Related]
4. Buspirone in the treatment of tardive dyskinesia.
Moss LE; Neppe VM; Drevets WC
J Clin Psychopharmacol; 1993 Jun; 13(3):204-9. PubMed ID: 8102622
[TBL] [Abstract][Full Text] [Related]
5. Rapid improvement of neuroleptic-induced tardive dyskinesia with levetiracetam in an interictal psychotic patient.
Chen PH; Liu HC
J Clin Psychopharmacol; 2010 Apr; 30(2):205-7. PubMed ID: 20520300
[No Abstract] [Full Text] [Related]
6. Efficacy and tolerability of levetiracetam in Parkinson disease patients with levodopa-induced dyskinesia.
Lyons KE; Pahwa R
Clin Neuropharmacol; 2006; 29(3):148-53. PubMed ID: 16772814
[TBL] [Abstract][Full Text] [Related]
7. [Utility of quetiapine in tardive dyskinesia].
Navarro Pacheco BV; Montejo González AL; Martín Carrasco M
Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511
[TBL] [Abstract][Full Text] [Related]
8. Levetiracetam in tardive dyskinesia: an open label study.
Konitsiotis S; Pappa S; Mantas C; Mavreas V
Mov Disord; 2006 Aug; 21(8):1219-21. PubMed ID: 16637037
[TBL] [Abstract][Full Text] [Related]
9. Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease.
Zesiewicz TA; Sullivan KL; Maldonado JL; Tatum WO; Hauser RA
Mov Disord; 2005 Sep; 20(9):1205-9. PubMed ID: 15954135
[TBL] [Abstract][Full Text] [Related]
10. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial.
Lee JG; Shin BS; Lee YC; Park SW; Kim YH
Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029
[TBL] [Abstract][Full Text] [Related]
11. Vitamin E in the treatment of tardive dyskinesia.
Akhtar S; Jajor TR; Kumar S
J Postgrad Med; 1993; 39(3):124-6. PubMed ID: 7914238
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, placebo-controlled trial of levetiracetam for dyskinesia in Parkinson's disease.
Wong KK; Alty JE; Goy AG; Raghav S; Reutens DC; Kempster PA
Mov Disord; 2011 Jul; 26(8):1552-5. PubMed ID: 21538524
[TBL] [Abstract][Full Text] [Related]
13. Vitamin B6 in treatment of tardive dyskinesia: a preliminary case series study.
Lerner V; Kaptsan A; Miodownik C; Kotler M
Clin Neuropharmacol; 1999; 22(4):241-3. PubMed ID: 10442256
[TBL] [Abstract][Full Text] [Related]
14. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.
Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):761-4. PubMed ID: 18201810
[TBL] [Abstract][Full Text] [Related]
15. Focus on lower risk of tardive dyskinesia with atypical antipsychotics.
Nasrallah HA
Ann Clin Psychiatry; 2006; 18(1):57-62. PubMed ID: 16517454
[TBL] [Abstract][Full Text] [Related]
16. Correlation of increase in phosphene threshold with reduction of migraine frequency: observation of levetiracetam-treated subjects.
Young W; Shaw J; Bloom M; Gebeline-Myers C
Headache; 2008; 48(10):1490-8. PubMed ID: 19076647
[TBL] [Abstract][Full Text] [Related]
17. [Tiapride in the treatment of irreversible tardive dyskinesia--initial experiences].
Leblhuber F; Reisecker F; Bengesser G
Z Gerontol; 1987; 20(1):49-51. PubMed ID: 2883781
[TBL] [Abstract][Full Text] [Related]
18. Effects of levetiracetam on EEG abnormalities in juvenile myoclonic epilepsy.
Specchio N; Boero G; Michelucci R; Gambardella A; Giallonardo AT; Fattouch J; Di Bonaventura C; de Palo A; Ladogana M; Lamberti P; Vigevano F; La Neve A; Specchio LM
Epilepsia; 2008 Apr; 49(4):663-9. PubMed ID: 18266754
[TBL] [Abstract][Full Text] [Related]
19. Levetiracetam in the prophylaxis of migraine with aura: a 6-month open-label study.
Brighina F; Palermo A; Aloisio A; Francolini M; Giglia G; Fierro B
Clin Neuropharmacol; 2006; 29(6):338-42. PubMed ID: 17095897
[TBL] [Abstract][Full Text] [Related]
20. Open label, long-term, pragmatic study on levetiracetam in the treatment of juvenile myoclonic epilepsy.
Specchio LM; Gambardella A; Giallonardo AT; Michelucci R; Specchio N; Boero G; La Neve A
Epilepsy Res; 2006 Sep; 71(1):32-9. PubMed ID: 16814521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
